2016 American Transplant Congress
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.
Background: The renal allograft function and blood pressure (BP) control after renal artery angioplasty±stenting for transplant renal artery stenosis (TRAS) is unclear. We aim to…2016 American Transplant Congress
Should Renin Angiotensin Blockade Be the Mainstay of Hypertension Treatment in Kidney Donors?
Introduction: The prevalence of hypertension (HTN) in kidney donors is comparable to what is seen in the general population. How HTN in donors is treated…2016 American Transplant Congress
Landscape of Hypertension Treatment in Former Kidney Donors.
The aim of this analysis is to describe the general epidemiological features for the development of hypertension and the most frequent medical therapies prescribed in…2016 American Transplant Congress
Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
Background;Renal transplantation is the treatment of choice for individuals with end stage renal disease (ESRD).Method; This is a retrospective review of eight live related renal…2016 American Transplant Congress
An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?
Lack of health insurance has been related lack of access to health care, poorer health, and increased mortality. In this study, we investigate sociodemographic predictors…2016 American Transplant Congress
Treatments Against Renin-Angiotensin-Aldosterone System Could Influence FGF23 and Klotho Levels in Renal Transplant Recipients.
Purpose: Angiotensin-converting enzyme inhibitor ( ACEI) and angiotensin II receptor blocker (ARB) are frequently used in post transplant hypertension. Recent trials reported that renin-angiotensin-aldosterone system…2015 American Transplant Congress
Clinical and Radiological Predictors of Transplant Renal Artery Stenosis (TRAS)
Elevated peak systolic velocity (PSV) on Doppler ultrasound at the transplant renal artery (TRA) does not always correlate with true transplant renal artery stenosis (TRAS)…2015 American Transplant Congress
Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study
Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA.
Background and aim: Reduced renal function is nearly a universal complication experienced by organ transplant recipients, in part related to nephrotoxicity of calcineurin inhibitors. With…2015 American Transplant Congress
Serum Uric Acid Is Associated With Hypertension in Kidney Donors
Introduction:Uric acid has been linked to the development of hypertension and possibly CKD. Moreover, some preliminary data suggests that lowering uric acid maybe associated with…2015 American Transplant Congress
Blood Pressure Evaluation by Three Different Modalities in Living Kidney Donors
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Screening for hypertension (HTN) is an important element of the living kidney donor (LKD) evaluation process. Since there are no general consensus about the blood…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- Next Page »